Advertisement
Screener

Renalytix plc (RENXF) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

1.6 / 5 stars · 14/44 Roast Me

Renalytix plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • Renalytix plc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 0.00 shares.
  • Renalytix plc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-06-30 was 0.00 shares.
  • Renalytix plc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-03-31 was 0.00 shares.
  • Renalytix plc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-12-31 was 0.00 shares.
  • Renalytix plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares.
  • Renalytix plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 0.00 shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2024-09-300.00 shares
10-Q · filed 2024-11-19
0.00 shares
derived: sum of 4 quarters · filed 2024-11-19
2024-06-300.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30
0.00 shares
10-K · filed 2024-09-30
2024-03-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15
0.00 shares
derived: sum of 4 quarters · filed 2024-05-15
2023-12-310.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14
0.00 shares
derived: sum of 4 quarters · filed 2024-02-14
2023-09-300.00 shares
10-Q · filed 2023-11-14
0.00 shares
derived: sum of 4 quarters · filed 2023-11-14
2023-06-300.00 shares
derived: 10-K 12 month − 6-K 9 month · filed 2023-09-28
0.00 shares
10-K · filed 2023-09-28
2023-03-310.00 shares
derived: 6-K 9 month − 6-K 6 month · filed 2023-06-09
0.00 shares
derived: sum of 4 quarters · filed 2023-06-09
2022-12-310.00 shares
derived: 6-K 6 month − 6-K 3 month · filed 2023-03-30
0.00 shares
derived: sum of 4 quarters · filed 2023-03-30
2022-09-300.00 shares
6-K · filed 2022-11-30
2022-06-300.00 shares
derived: 20-F 12 month − 6-K 9 month · filed 2022-10-31
100.72K shares
20-F · filed 2022-10-31
2022-03-310.00 shares
derived: 6-K 9 month − 6-K/A 6 month · filed 2022-06-30
2021-06-30150.00K shares
20-F/A · filed 2022-08-01